Since KLF5 has been shown to mediate the function of both APC and RAS, and mutations in APC and KRAS are common events in colorectal cancer, we examined the role of KLF5 in mediating intestinal tumor formation in mice compound for ApcMin and intestine-specific KRASV12 mutations in the current study. This evidence concerns the gene KLF5 and colorectal cancer.